Möchten Sie immer auf dem neuesten Stand bleiben?

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In uniQure (QURE) To Contact Him Directly To Discuss Their Options If you purchased or...

Châtillon, France, le 10 février (22 :30 CET) 2026 DBV Technologies présentera des données complémentaires issues de l'étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de...

Châtillon, France, February 10, 2026 DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in...

MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January...

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

TUCSON, Ariz., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total...

Cervco launches the first at-home gut test designed for cognitive wellness, analyzing bacteria research links to gut-brain communication. Now available.

Chicago, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global 5G in healthcare market was valued at US$ 67.22 billion in 2024 and is projected to hit the...

“Our practice focuses on restoring investor capital and ensuring corporate accountability to uphold market integrity,” said Peretz Bronstein.

Woburn, MA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults...

Lehi, UT, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hyagen Medical, a regulatory compliance and education company specializing in regenerative medicine, announced today the launch of a national initiative...

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

Sanofi finalise l’acquisition de Dynavax Paris, le 10 février 2026. Sanofi a annoncé aujourd’hui avoir finalisé l’acquisition de Dynavax Technologies Corporation (Dynavax). L’acquisition comprend le...

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...

BELLEVUE, Wash., Feb. 10, 2026 (GLOBE NEWSWIRE) -- A new peer-reviewed study led by Truveta Research and collaborators finds that the US Food and Drug Administration’s (FDA) March 2024 expansion of...

BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced the strategic expansion of its support of inflammatory bowel disease clinical trials on the...

PARAMUS, NJ, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal...

MOUNTAIN VIEW, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and...

Kennewick, WA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™ (PRnT™) with its innovative RadioGel® technology, today...

DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...

BOOST Pharma announces the appointment of seasoned biotech entrepreneur Hans Schambye, MD, PhD, as its new Chief Executive Officer.

Oak Ridge, TN, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced its intention to transition its primary...

Additional exchange listing expected to increase token access and contribute to expanded secondary market liquidity for RAIN Nes-Ziona, Israel, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Enlivex...

Aardvark Therapeutics announced a Phase 3 HERO trial protocol amendment expanding eligibility for patients with Prader-Willi Syndrome.

MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January...

Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of 99 participants, each of whom was randomized to receive either BRTX-100 or...

FREIBURG, Germany, Feb. 10, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in active implantable medical technologies, today announced the successful second implantation of its proprietary...

Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...

MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and Chief...

-Five poster presentations highlight clinical advancement of neffy, real-world usability and advantages of needle-free epinephrine delivery -Longer shelf life of nasal epinephrine compared with...

Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP...

Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA), designed to streamline the final approval...

PHILADELPHIA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical...

36 abstracts to be presented across Regeneron-invented therapies, including first-time Phase 3 presentations for two distinct investigational allergen-blocking antibodies for cat and birch allergies ...

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "AI in Oncology Market, till 2040: Distribution by Type of Cancer, Type of End User, and Geographical Regions: Industry Trends and Global Forecasts"...

Chicago, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The global tetracyclines market size was valued at USD 3.38 billion in 2025 and is projected to hit the market valuation of USD 5.63 billion by 2035 at a...

Global Calibration Services Market Size, Share & Segmentation Analysis, By Proofreading, Service Proofreading, Application, Region, and Forecasts 2035

Ottawa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According to data published by Precedence Research, the global tissue and regenerative engineering sector encompasses companies developing biomaterials,...

Chicago, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The global anti-biofilm agents market is experiencing a robust surge in demand primarily driven by the escalating prevalence of multidrug-resistant...

Ottawa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The global single-use disposable medical devices market size is valued at USD 187.51 billion in 2026 and is expected to surpass around USD 310.92 billion by...

Pratteln, Schweiz, 10. Februar 2026 – Santhera Pharmaceuticals (SIX: SANN) gab heute die Ernennung von Stifel Nicolaus Europe Limited (“Stifel”) zum Finanzberater mit Schwerpunkt auf Kapitalmärkten...

Pratteln, Switzerland, February 10, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced the appointment of Stifel Nicolaus Europe Limited (“Stifel”) as corporate finance advisor with a focus...

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District...

NEW YORK, NY, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Propr®, the fluoride free oral care brand founded by acclaimed periodontist Dr. Jack Gruber, today announced the launch of Propr Picks, a thoughtfully...

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Alvotech...

Investors who lost money in ALVO after its stock plunged 34% due to allegedly misleading financial statements are urged to contact Hagens Berman.

Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at 10.5 billion in 2024 and is expected to reach US$ 16.5 billion by 2033,...

Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global ureteral stents market was valued at 412.43 million in 2024 and is expected to reach US$ 685.05 million by 2033, growing at a CAGR of 5.8% from...

New york, USA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight ...